Krishna Institute of Medical Sciences Intrinsic Value
Krishna Institute of Medical Sciences intrinsic value. Krishna Institute of Medical Sciences (KIMS) median intrinsic value is ₹450.00 from 9 valuation models (range ₹230–₹1460), vs current price ₹767.80 — -41.4% downside (Trading Above Calculated Value), margin of safety -70.6%. For current market price and key ratios, visit KIMS share price screener.
KIMS Valuation Methods Summary — DCF, Graham Number & P/E
Krishna Institute of Medical Sciences intrinsic value across 9 models vs current price ₹767.80 — upside/downside and value range per method. Browse KIMS income statement for revenue, profit, balance sheet and cash flow data.
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| P/E Based Valuation | earnings | ₹230.34 | ₹184.27 - ₹276.41 | -70.0% | EPS: ₹7.16, Sector P/E: 22x |
| Book Value Method | asset | ₹639.75 | ₹575.77 - ₹703.73 | -16.7% | Book Value/Share: ₹319.88, P/B: 2.0x |
| Revenue Multiple Method | revenue | ₹1376.00 | ₹1238.40 - ₹1513.60 | +79.2% | Revenue/Share: ₹688.00, P/S: 2.0x |
| EBITDA Multiple Method | earnings | ₹1460.00 | ₹1314.00 - ₹1606.00 | +90.2% | EBITDA: ₹1168.00Cr, EV/EBITDA: 10x |
| Simple DCF (5Y) | dcf | ₹777.51 | ₹622.01 - ₹933.01 | +1.3% | CF Growth: 12.1%, Discount: 15% |
| PEG Ratio Method | growth | ₹230.34 | ₹207.31 - ₹253.37 | -70.0% | EPS Growth: 8.0%, Fair P/E: 6.4x |
| Growth Adjusted P/E | growth | ₹230.34 | ₹207.31 - ₹253.37 | -70.0% | Revenue Growth: 6.0%, Adj P/E: 15.5x |
| ROE Based Valuation | profitability | ₹450.00 | ₹405.00 - ₹495.00 | -41.4% | ROE: 11.7%, P/E Multiple: 12x |
| Graham Defensive Method | conservative | ₹230.34 | ₹207.31 - ₹253.37 | -70.0% | EPS: ₹7.16, BVPS: ₹319.88 |
KIMS Intrinsic Value vs Market Price — All Valuation Models
Krishna Institute of Medical Sciences fair value range ₹230–₹1460 vs current market price ₹767.80 across 9 valuation models. Analyse KIMS FII DII holdings to track promoter, FII and institutional holdings.
KIMS Intrinsic Value Analysis — Undervalued or Overvalued?
Krishna Institute of Medical Sciences median intrinsic value ₹450.00, current price ₹767.80 — Trading Above Calculated Value by 41.4%, margin of safety -70.6%.
What is the intrinsic value of KIMS?
Based on our comprehensive analysis using 9 different valuation methods, the estimated intrinsic value of Krishna Institute of Medical Sciences (KIMS) is ₹450.00 (median value). With the current market price of ₹767.80, this represents a -41.4% variance from our estimated fair value.
The valuation range spans from ₹230.34 to ₹1460.00, indicating ₹230.34 - ₹1460.00.
Is KIMS undervalued or overvalued?
Based on our multi-method analysis, Krishna Institute of Medical Sciences (KIMS) appears to be trading above calculated value by approximately 41.4%.
KIMS Financial Health — Key Ratios vs Industry Benchmarks
Krishna Institute of Medical Sciences financial ratios — ROE, debt-to-equity, profit margins and liquidity vs industry benchmarks and their impact on intrinsic value.
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Return on Equity | 11.7% | Industry Standard: 15%+ | Above 10% | Measures shareholder return efficiency |
| Operating Margin | 19.0% | Industry Standard: 20%+ | Above 10% | Indicates operational efficiency level |
| Asset Turnover Ratio | 0.71x | Industry Standard: 1.0x+ | Above 0.5x | Measures asset utilization efficiency |
KIMS Cash Flow Quality — Operating & Free Cash Flow
Krishna Institute of Medical Sciences operating cash flow, free cash flow, quality rating and sustainability score by period — key inputs to DCF intrinsic value calculation.
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2026 | ₹511 Cr | ₹-215 Cr | Positive Operating Cash Flow | 6/10 |
| March 2025 | ₹582 Cr | ₹24 Cr | Positive Free Cash Flow | 7/10 |
| March 2024 | ₹521 Cr | ₹145 Cr | Positive Free Cash Flow | 7/10 |
| March 2023 | ₹432 Cr | ₹224 Cr | Positive Free Cash Flow | 8/10 |
| March 2022 | ₹324 Cr | ₹118 Cr | Positive Free Cash Flow | 7/10 |